Panome Bio, a leading provider of multi-omic services, has added transcriptional profiling to its suite of discovery tools.

The acquisition includes Microbiome Insights’ CAP-accredited Canadian laboratory and rich intellectual property, boosting Mapmygenome’s scientific prowess.

(“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced that its research ...

Demand, Trends, ForecastAccording to Straits Research, The Bioinformatics Market size was valued at USD XX Billion in 2023 to ...

A recent study published in Nature Communications provides insight into how APOE isoforms alter human microglia activity in ...

A new study investigates how APOE isoforms differentially affect human microglia function in Alzheimer's disease ...